Home Strategic Acquisition Advances Regenerative Medicine
 

Keywords :   


Strategic Acquisition Advances Regenerative Medicine

2013-06-19 06:00:00| Industrial Newsroom - All News for Today

Instron, a leading provider of testing equipment solutions designed to evaluate mechanical properties of materials and components, is pleased to announce the acquisition of Tissue Growth Technologies (TGT), a premier supplier of commercial bioreactors to grow and stimulate developing tissues. <br /> <br /> TGT will become part of the Instron division of ITWs Test and Measurement business. In partnership, we are excited to offer an instrumentation platform that is uniquely designed to cater to ...

Tags: medicine strategic acquisition advances

Category:Industrial Goods and Services

Latest from this category

All news

19.11POWTEX2024 The 25th International Powder Technology Exhibition Tokyo
Industrial Goods and Services »
27.11kazu.boo BG
27.11 2
27.112493 33500 Bloodborne gecco
27.11
27.11
27.11Yuki
27.11RG SPECIAL COATING]
27.11DIALOGUE
More »